Najam A. Sharif - Concepedia

Author

Najam A. Sharif

Also Known As

BindingDB, J Hughes, N A M Sharif, N A Sharif, N A Sharif,, N A. Sharif, N SHARIF, N. A. SHARIF, N. A. Sharif, N.A Sharif

232

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

Alcon (United States)Alcon (China)University of Maryland, Baltimore University of Southampton

About

Najam A. Sharif is an author at Alcon (United States) specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	64	2.6K
2	Natural Sciences	11	12	504
3	Social Sciences	7	7	417
4	Health Sciences	6	6	275
5	Public Health	1	1	22

Najam A. Sharif

120

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Ocular Hypotensive FP Prostaglandin (PG) Analogs: PG Receptor Subtype Binding Affinities and Selectivities, and Agonist Potencies at FP and Other PG Receptors in Cultured Cells Najam A. Sharif, Curtis R. Kelly, Julie Y. Crider, Journal of Ocular Pharmacology and Therapeutics Ocular DiseaseMedicinal ChemistryRetinaAgonist PotenciesBimatoprost Acid	2003	159
Effects ofl-glutamate and related amino acids upon the release of [3H]dopamine from rat striatal slices Peter Roberts‎, Najam A. Sharif Brain Research NeurophysiologyNeuroanatomyMedicinePhysiologyRat Striatal Slices	1978	135
Striatal glutamatergic function: Modifications following specific lesions Peter Roberts‎, Gethin J. McBean, Najam A. Sharif, Brain Research NeurophysiologyNeuroanatomyNeurologyNeuroscienceCentral Nervous System	1982	132
Human Trabecular Meshwork Cell Responses Induced by Bimatoprost, Travoprost, Unoprostone, and other FP Prostaglandin Receptor Agonist Analogues Najam A. Sharif, Curtis R. Kelly, Julie Y. Crider Investigative Ophthalmology & Visual Science	2003	122
Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. Najam A. Sharif, S X Xu, Steven T. Miller, Journal of Pharmacology and Experimental Therapeutics	1996	112
Immortalized human corneal epithelial cells for ocular toxicity and inflammation studies. Elizabeth Offord, Najam A. Sharif, Katherine Macé, PubMed	1999	110
Comparative Effects of Topical Ocular Anti-Allergy Drugs on Human Conjunctival Mast Cells John M. Yanni, Steven T. Miller, Daniel A. Gamache, Annals of Allergy Asthma & Immunology AsthmaAllergyOphthalmologyAllergy MedicineImmunotherapy	1997	102
AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor. Brenda Walker Griffin, Peter G. Klimko, Julie Y. Crider, PubMed PharmacotherapyExperimental PharmacologyProstaglandin FInflammationMolecular Pharmacology	1999	101
The pharmacological properties of the peptide, endothelin Richard M. Eglen, A.D. Michel, Najam A. Sharif, British Journal of Pharmacology Molecular PharmacologyHypertensionCardiovascular DiseaseMedicineVascular Adaptation	1989	99
Agonist Activity of Bimatoprost, Travoprost, Latanoprost, Unoprostone Isopropyl Ester and Other Prostaglandin Analogs at the Cloned Human Ciliary Body FP Prostaglandin Receptor Najam A. Sharif, Curtis R. Kelly, Julie Y. Crider Journal of Ocular Pharmacology and Therapeutics ImmunologyPharmacotherapyExperimental PharmacologyFp Prostaglandin ReceptorOther Prostaglandin Analogs	2002	97

Page 1